Table 3.

Multivariate analysis with prognostic factors for overall survival

Variables	Entire cohort of breast cancers (n=146)			ER-positive (n=102)
	HR	95% CI	p-value	HR	95% CI	p-value
ER+	0.30	0.13 - 0.71	0.006
Her2+	0.66	0.27 - 1.60	0.354	NA
LN+	1.24	0.22 - 7.05	0.810	NA
Size > 20mm	1.77	0.39 - 7.96	0.460	NA
Tumor stage	8.10	2.03 - 39.81	0.004	11.76	2.70 - 51.23	0.001
H3K27me3 high	0.18	0.07 - 0.49	0.001	0.21	0.06 - 0.72	0.013
EZH2 high	3.34	1.20 - 9.27	0.021	6.31	1.42 - 28.13	0.016
UTX high	0.68	0.27 - 1.74	0.423	NA